FindTrial
Sign In

Effect of Duralabhadi Kwatha in the Management of Urinary tract infections w.s.r. to Pittaja Mutrakrichhra

A Clinical Study to Evaluate the Effect of Duralabhadi Kwatha in the Management of Urinary tract infections w.s.r. to Pittaja Mutrakrichhra

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/033983
Enrollment
25
Registered
2021-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Duralabhadi Kwatha: Duralabhadi Kwatha - 25 ml twice a day for 21 days Control Intervention1: Not Applicable: Not Applicable

Sponsors

Principal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Both fresh and recurrent cases will be selected. 2)Patients who present with sign and symptoms of Pittaja Mutrakrichhra/UTI. 3)Patients willing for trial.

Exclusion criteria

Exclusion criteria: 1)Patients not willing for trail. 2)Patients with chronic renal failure and diabetes mellitus will be excluded. 3)Patient with defects in voiding mechanism as incontinence of urine and atonic bladder.

Design outcomes

Primary

MeasureTime frame
Fulfillment of objective and subjective criteriaTimepoint: 3 weeks—

Secondary

MeasureTime frame
Change in clinical symptomsTimepoint: 3 weeks—

Countries

India

Contacts

Public ContactDr Kumari Surbhi

R.G.G.P.G Ayurvedic College, Paprola

dranjana269@gmail.com9418312324

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026